Vinelbine 50mg Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Vinorelbine (50mg)
Overview Vinelbine 50mg Injection
Vinblastine (50mg injection) is a chemotherapy agent indicated for breast and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your oncologist based on your condition and may vary. Strictly adhere to the prescribed regimen; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical supervision. Common adverse reactions include nausea, emesis, asthenia, fatigue, and alopecia. This drug can suppress blood cell production (leukopenia, anemia), raising infection risk. Regular blood monitoring (including complete blood count, liver function tests, and uric acid levels) is essential. Prior to treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications, as drug interactions are possible. Pregnancy and breastfeeding are contraindicated. Both partners should employ reliable contraception during and after treatment. Male patients should consult their physician regarding sperm banking options.
Primary Ingredients of Vinelbine 50mg Injection
No text was provided to rewrite.
Uses of Vinelbine 50mg Injection
Carcinoma of the breast | Lung adenocarcinoma
Major Benefits of Vinelbine 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Vinelbine 50mg Injection:
- Nausea
- Vomiting
- Weakness
- Fatigue
- Hair loss
- Low blood platelets
- Increased liver enzymes
- Fever
- Anemia (low number of red blood cells)
- Bleeding
- Constipation
How to use Vinelbine 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Vinelbine 50mg Injection works:
Vinblastine's 50mg injectable formulation inhibits DNA replication within cancerous cells, thereby arresting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vinelbine 50mg Injection may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Vinelbine 50mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional circumstances involving a life-threatening condition, a physician may consider its use only if the potential benefits substantially outweigh the known risks. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding is contraindicated during treatment with Vinelbine 50mg Injection due to potential infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by a 50mg Vinelbine injection.
KidneySAFE IF PRESCRIBED
Vinblastine 50mg Injection can be used in patients with kidney impairment without dose modification. Nevertheless, consult your physician regarding any pre-existing renal conditions.
LiverCAUTION
For patients with hepatic impairment, Vinelbine 50mg Injection requires careful administration. Dosage modification may be necessary. Physician consultation is recommended. Routine monitoring of liver function is advised during treatment.
What if you forget to take Vinelbine 50mg Injection :
NA
Facts to Know About Vinelbine 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Vinca-derived anticancer agents |
| Developing Habits | No. |
| Type of Treatment | Cancer Medications |
| Action Class | Vinca Alkaloid Antimicrotubule Agents |
3,018 People bought this recently